Collen Cuffaro, a venture investor from Canaan Partners, will share best practices for getting early stage capital or Blavatnik Accelerator funding for your biotech idea. Colleen Cuffaro is a Principal with Canaan Partners. Colleen’s investment focus is early stage biopharmaceutical companies. Her interests lie in transformative medical technologies that deliver value to providers and patients alike. In her time at Canaan, Colleen helped launch the Canaan-Yale Fellowship program. Colleen previously worked as a chemist at Pharmaceutical Manufacturing and Research Services, Inc. She holds a Ph.D. in Cellular and Molecular Physiology from Yale University and a B.A. in Chemistry from the University of Pennsylvania.
Learn more about the Blavatnik Fund for Innovation at Yale: blavatnik.ocr.yale.edu